In Vitro Synergistic Effects of Omadacycline with Other Antimicrobial Agents against Mycobacterium abscessus
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.01579-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Keiji Fujiwara und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan. Hauptthemen laut MEDLINE: Mycobacterium abscessus, Mycobacterium Infections, Nontuberculous, Anti-Infective Agents, Mycobacterium. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
The clinical importance of Mycobacterium abscessus species (MABS) infections has been increasing. However, the standard treatment regimens recommended in the current guidelines often result in unfavorable outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan.
- Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan.
- Department of Basic Mycobacteriosis, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
- Department of Clinical Mycobacteriosis, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
- Division of Clinical Research, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan.
ORCID-Profile: Keiji Fujiwara, Akio Aono, Kozo Morimoto, Yuta Morishige, Yuriko Igarashi, Yoshiro Murase, Hiroyuki Yamada, Satoshi Mitarai
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Fujiwara, K., Aono, A., Asami, T., Morimoto, K., Kamada, K., Morishige, Y., Igarashi, Y., Chikamatsu, K., Murase, Y., Yamada, H., Takaki, A., & Mitarai, S. (2023). In Vitro Synergistic Effects of Omadacycline with Other Antimicrobial Agents against Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01579-22
Vancouver
Fujiwara K, Aono A, Asami T, Morimoto K, Kamada K, Morishige Y, et al. In Vitro Synergistic Effects of Omadacycline with Other Antimicrobial Agents against Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01579-22
BibTeX
@article{Fujiwara2023,
author = {Fujiwara, Keiji and Aono, Akio and Asami, Takahiro and Morimoto, Kozo and Kamada, Keisuke and Morishige, Yuta and Igarashi, Yuriko and Chikamatsu, Kinuyo and Murase, Yoshiro and Yamada, Hiroyuki and Takaki, Akiko and Mitarai, Satoshi},
title = {In Vitro Synergistic Effects of Omadacycline with Other Antimicrobial Agents against Mycobacterium abscessus},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.01579-22}
}
EUVIMED